title: Understanding and treating opioid addiction in a patient with cancer pain.
authors.affiliation: Division of Hematology-Oncology, Northwestern University; Feinberg School of Medicine, Chicago, IL, USA.
authors.forename: Sheetal
authors.initials: S
authors.lastname: Kircher
authors.forename: James
authors.initials: J
authors.lastname: Zacny
authors.forename: Sean M
authors.initials: SM
authors.lastname: Apfelbaum
authors.forename: Steve
authors.initials: S
authors.lastname: Passik
authors.forename: Ken
authors.initials: K
authors.lastname: Kirsch
authors.forename: Maureen
authors.initials: M
authors.lastname: Burbage
authors.forename: Michelle
authors.initials: M
authors.lastname: Lofwall
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006556:Heroin Dependence / Q000150:complications; D006728:Hormones / Q000378:metabolism; D006801:Humans; D004091:Hydromorphone / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*
chemical_list: D000701:Analgesics, Opioid; D000970:Antineoplastic Agents; D006728:Hormones; D003561:Cytarabine; D004091:Hydromorphone; D003630:Daunorubicin